Found: 127
Select item for more details and to access through your institution.
Publisher Correction: EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary.
- Published in:
- Diabetologia, 2024, v. 67, n. 11, p. 2375, doi. 10.1007/s00125-024-06196-3
- By:
- Publication type:
- Article
Antiviral therapy for chronic hepatitis B: are we doing any good to patients?
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 64, n. 2, p. 223, doi. 10.1093/jac/dkp189
- By:
- Publication type:
- Article
SARS-CoV-2 Viral Persistence Based on Cycle Threshold Value and Liver Injury in Patients With COVID-19.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 6, p. 1, doi. 10.1093/ofid/ofab205
- By:
- Publication type:
- Article
CAGE‐B and SAGE‐B models better predict the hepatitis B virus‐related hepatocellular carcinoma after 5‐year entecavir treatment than PAGE‐B.
- Published in:
- Journal of Digestive Diseases, 2023, v. 24, n. 2, p. 113, doi. 10.1111/1751-2980.13172
- By:
- Publication type:
- Article
Epidemiology of nonalcoholic fatty liver disease in non‐obese populations: Meta‐analytic assessment of its prevalence, genetic, metabolic, and histological profiles.
- Published in:
- Journal of Digestive Diseases, 2020, v. 21, n. 7, p. 372, doi. 10.1111/1751-2980.12871
- By:
- Publication type:
- Article
Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.
- Published in:
- Journal of Digestive Diseases, 2016, v. 17, n. 8, p. 538, doi. 10.1111/1751-2980.12359
- By:
- Publication type:
- Article
High incidence of hepatocellular carcinoma and cirrhotic complications in patients with psychiatric illness: a territory-wide cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The effect of caffeine and alcohol consumption on liver fibrosis - a study of 1045 Asian hepatitis B patients using transient elastography.
- Published in:
- Liver International, 2011, v. 31, n. 7, p. 1047, doi. 10.1111/j.1478-3231.2011.02555.x
- By:
- Publication type:
- Article
Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis.
- Published in:
- Liver International, 2008, v. 28, n. 1, p. 79, doi. 10.1111/j.1478-3231.2007.01576.x
- By:
- Publication type:
- Article
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarate.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 9, p. 4440, doi. 10.1002/jmv.27863
- By:
- Publication type:
- Article
Diagnosis and non‐invasive assessment of MASLD in type 2 diabetes and obesity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 1, p. S23, doi. 10.1111/apt.17866
- By:
- Publication type:
- Article
CAMP‐B score predicts the risk of hepatocellular carcinoma in patients with chronic hepatitis B after HBsAg seroclearance.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 10, p. 1223, doi. 10.1111/apt.17933
- By:
- Publication type:
- Article
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease – The Gut and Obesity in Asia (GO‐ASIA) Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 6, p. 774, doi. 10.1111/apt.17891
- By:
- Publication type:
- Article
Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 150, doi. 10.1111/apt.17846
- By:
- Publication type:
- Article
Editorial: Assessing advanced fibrosis in metabolic‐associated steatotic liver disease—the MAFLD fibrosis score. Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
MAFLD fibrosis score: Using routine measures to identify advanced fibrosis in metabolic‐associated fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 11/12, p. 1194, doi. 10.1111/apt.17722
- By:
- Publication type:
- Article
The silent burden of non‐alcoholic fatty liver disease in the elderly: A global burden of disease analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1062, doi. 10.1111/apt.17714
- By:
- Publication type:
- Article
Editorial: Can liver fat quantification stratify cardiovascular risk in type 2 diabetes?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 10, p. 1107, doi. 10.1111/apt.17677
- By:
- Publication type:
- Article
Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 9, p. 920, doi. 10.1111/apt.17699
- By:
- Publication type:
- Article
Incidence of hepatocellular carcinoma and mortality in chronic viral hepatitis in an Asian population with and without HIV infection.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 814, doi. 10.1111/apt.17654
- By:
- Publication type:
- Article
improvement of cardiovascular risk factor control in patients with type 2 diabetes and nonalcoholic fatty liver disease--time for action! Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1172, doi. 10.1111/apt.17474
- By:
- Publication type:
- Article
Trends in risk factor control and treatment among patients with non-alcoholic fatty liver disease and type 2 diabetes between 2000 and 2020: A territory-wide study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 10, p. 1103, doi. 10.1111/apt.17428
- By:
- Publication type:
- Article
Secondary bile acids improve risk prediction for non‐invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 8, p. 872, doi. 10.1111/apt.17362
- By:
- Publication type:
- Article
Letter: vaccination for global control of hepatitis B—from prevention to elimination. Authorsʼ reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 11/12, p. 1629, doi. 10.1111/apt.17271
- By:
- Publication type:
- Article
Universal HBV vaccination dramatically reduces the prevalence of HBV infection and incidence of hepatocellular carcinoma.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 5, p. 869, doi. 10.1111/apt.17120
- By:
- Publication type:
- Article
Letter: systematic review with meta‐analysis on the impact of functional cure on clinical outcomes in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 5, p. 616, doi. 10.1111/apt.16758
- By:
- Publication type:
- Article
Editorial: central obesity is a risk factor for hepatocellular carcinoma in Asian patients with chronic hepatitis B on anti‐viral therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 5, p. 722, doi. 10.1111/apt.16498
- By:
- Publication type:
- Article
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 4, p. 470, doi. 10.1111/apt.16487
- By:
- Publication type:
- Article
Editorial: metagenome‐assembled genomes in non‐alcoholic fatty liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 6, p. 755, doi. 10.1111/apt.16280
- By:
- Publication type:
- Article
Similarly low risk of hepatocellular carcinoma after either spontaneous or nucleos(t)ide analogue‐induced hepatitis B surface antigen loss.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 2, p. 321, doi. 10.1111/apt.16174
- By:
- Publication type:
- Article
Characterization and correction of the effects of hepatic iron on T<sub>1ρ</sub> relaxation in the liver at 3.0T.
- Published in:
- Magnetic Resonance in Medicine, 2022, v. 88, n. 4, p. 1828, doi. 10.1002/mrm.29310
- By:
- Publication type:
- Article
Macromolecular proton fraction mapping based on spin‐lock magnetic resonance imaging.
- Published in:
- Magnetic Resonance in Medicine, 2020, v. 84, n. 6, p. 3157, doi. 10.1002/mrm.28362
- By:
- Publication type:
- Article
Modelling the economic and clinical burden of non‐alcoholic steatohepatitis in East Asia: Data from Hong Kong.
- Published in:
- Hepatology Research, 2020, v. 50, n. 9, p. 1024, doi. 10.1111/hepr.13535
- By:
- Publication type:
- Article
Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy.
- Published in:
- PLoS ONE, 2015, v. 10, n. 9, p. 1, doi. 10.1371/journal.pone.0139310
- By:
- Publication type:
- Article
Higher Estimated Net Endogenous Acid Production May Be Associated with Increased Prevalence of Nonalcoholic Fatty Liver Disease in Chinese Adults in Hong Kong.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0122406
- By:
- Publication type:
- Article
Molecular Characterization of the Fecal Microbiota in Patients with Nonalcoholic Steatohepatitis – A Longitudinal Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062885
- By:
- Publication type:
- Article
Carboxyl-Terminal Truncated HBx Regulates a Distinct MicroRNA Transcription Program in Hepatocellular Carcinoma Development.
- Published in:
- PLoS ONE, 2011, v. 6, n. 8, p. 1, doi. 10.1371/journal.pone.0022888
- By:
- Publication type:
- Article
Reply to Allaire, M.; Thabut, D. Comment on "Wu et al. Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma. Cancers 2023, 15 , 2480"
- Published in:
- Cancers, 2024, v. 16, n. 4, p. 725, doi. 10.3390/cancers16040725
- By:
- Publication type:
- Article
Baveno VII Criteria Is an Accurate Risk Stratification Tool to Predict High-Risk Varices Requiring Intervention and Hepatic Events in Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2480, doi. 10.3390/cancers15092480
- By:
- Publication type:
- Article
Viral Load–Based Prediction of Hepatocellular Carcinoma Risk in Noncirrhotic Patients With Chronic Hepatitis B: A Multinational Study for the Development and External Validation of a New Prognostic Model.
- Published in:
- Annals of Internal Medicine, 2024, v. 177, n. 10, p. 1308, doi. 10.7326/M24-0384
- By:
- Publication type:
- Article
AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors.
- Published in:
- Liver International, 2024, v. 44, n. 10, p. 2724, doi. 10.1111/liv.16050
- By:
- Publication type:
- Article
Diagnostic accuracy of non‐invasive tests to screen for at‐risk MASH—An individual participant data meta‐analysis.
- Published in:
- Liver International, 2024, v. 44, n. 8, p. 1872, doi. 10.1111/liv.15914
- By:
- Publication type:
- Article
Serum PRO‐C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
- Published in:
- Liver International, 2024, v. 44, n. 5, p. 1129, doi. 10.1111/liv.15878
- By:
- Publication type:
- Article
Machine‐learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD‐related liver fibrosis.
- Published in:
- Liver International, 2024, v. 44, n. 3, p. 749, doi. 10.1111/liv.15818
- By:
- Publication type:
- Article
Risk of severe infection in patients with non‐alcoholic fatty liver disease: Implication on clinical management.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2057, doi. 10.1111/liv.15696
- By:
- Publication type:
- Article
A cholestatic pattern predicts major liver‐related outcomes in patients with non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 5, p. 1037, doi. 10.1111/liv.15232
- By:
- Publication type:
- Article
Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 581, doi. 10.1111/liv.14301
- By:
- Publication type:
- Article
Impact of dose and duration of corticosteroid on the risk of hepatitis flare in patients with chronic hepatitis B.
- Published in:
- Liver International, 2019, v. 39, n. 2, p. 271, doi. 10.1111/liv.13953
- By:
- Publication type:
- Article
Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta‐analysis of a complex issue.
- Published in:
- Liver International, 2018, v. 38, n. 3, p. 503, doi. 10.1111/liv.13555
- By:
- Publication type:
- Article